✦ LIBER ✦

Enhancing prostate cancer cryotherapy using tumour necrosis factor related apoptosis-inducing ligand (TRAIL) sensitisation in an in vitro cryotherapy model

✍ Scribed by Mohamed Ismail; Richard Morgan; Kevin Harrington; John Davies; Hardev Pandha

Book ID: 116393125
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 562 KB
Volume: 59
Category: Article
ISSN: 0011-2240
DOI: 10.1016/j.cryobiol.2009.07.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ENHANCING PROSTATE CANCER CRYOTHERAPY US

ENHANCING PROSTATE CANCER CRYOTHERAPY USING TUMOUR NECROSIS FACTOR RELATED APOPTOSIS-INDUCING LIGAND (TRAIL) SENSITISATION IN A NOVEL IN VITRO MODEL

✍ Ismail, Mohamed; Kevin, Harrington; Morgan, Richard; Davies, John; Pandha, Harde 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 56 KB

Drug interactions between the proteasome

Drug interactions between the proteasome inhibitor bortezomib and cytotoxic chemotherapy, tumor necrosis factor (TNF), and TNF-related apoptosis-inducing ligand (TRAIL) in prostate cancer: An J, Sun Y-P, Adams J, Fisher M, Belldegrun A, Rettig MB, Veterans Administration Greater Los Angeles Healthcare System, Los Angeles, CA [J An, Y-PS, MF, MBR]; Millennium Pharmaceuticals, Inc., Cambridge, MA [J Adams]; and University of California at Los Angeles School of Medicine, Los Angeles, CA [AB, MBR]. Clinical Cancer Research 2003;9:4537–4545

✍ Gurkamal Chatta 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 18 KB